18F-FDG PET as a candidate for "qualified biomarker": Functional assessment of treatment response in oncology Journal Article
| Authors: | Larson, S. M.; Schwartz, L. H. |
| Article Title: | 18F-FDG PET as a candidate for "qualified biomarker": Functional assessment of treatment response in oncology |
| Keywords: | treatment outcome; functional assessment; note; united states; outcome assessment; positron emission tomography; methodology; radiopharmaceuticals; clinical practice; neoplasm; neoplasms; physician's practice patterns; biological marker; prostate specific antigen; breast cancer; tumor markers, biological; inflammation; lung cancer; practice guideline; tumor marker; outcome assessment (health care); standard; diagnostic agent; quantitative analysis; fluorodeoxyglucose f 18; fluorodeoxyglucose f18; positron-emission tomography; radiopharmaceutical agent; scintiscanning; clinical research; short survey; thyroid cancer; esophagus cancer; drug industry; practice guidelines |
| Journal Title: | Journal of Nuclear Medicine |
| Volume: | 47 |
| Issue: | 6 |
| ISSN: | 0161-5505 |
| Publisher: | Society of Nuclear Medicine |
| Date Published: | 2006-06-01 |
| Start Page: | 901 |
| End Page: | 903 |
| Language: | English |
| PUBMED: | 16741296 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 29" - "Export Date: 4 June 2012" - "CODEN: JNMEA" - "Source: Scopus" |
